Tilray | TRLY - Stock

Stock Price
9.09
Daily Change
-0.24 -2.57%
Monthly
-8.83%
Yearly
1,112.00%
Q2 Forecast
8.92

Tilray reported $282.79M in Stock for its fiscal quarter ending in June of 2025.





Stock Change Date
Akebia Therapeutics USD 15.61M 3.03M Dec/2025
Aurora Cannabis CAD 230.56M 8.6M Dec/2025
Avita Medical AUD 6.93M 614K Dec/2025
Canopy Growth CAD 105.56M 3.18M Dec/2025
Cronos Group USD 46.75M 1.42M Dec/2025
Divis Laboratories Ltd INR 32.36B 910M Mar/2025
Ionis Pharmaceuticals USD 10.47M 1.99M Sep/2025
Knight Therapeutics CAD 95.4M 2.91M Mar/2024
Moderna USD 332M 92M Sep/2025
Organigram Holdings CAD 132.71M 8.76M Dec/2025
Organon & Co USD 1.49B 34M Sep/2025
Revvity USD 379.5M 420K Dec/2025
Tilray USD 282.79M 11.9M Jun/2025
Viatris USD 4B 112.2M Dec/2025
Xeris Pharmaceuticals USD 68.67M 1.21M Dec/2025
Zealand Pharma A/S 10.7M 9.9M Dec/2024